1. Guo M, Ye L, Yu T, Han L, Li Q, Lou P, Gan T, Jin X, Xiao H, Meng G, Zhong J, Xu Y*. IL-1β enhances anti-viral effect of IFN-α on HCV replication by negatively modulating ERK2 activation.ACS Infect Dis. 2020 May 18.
2. Qi Y*, Han L, Qi Y, Jin X, Zhang B, Niu J, Zhong J, Xu Y*. Anti-flavivirus activity of polyoxometalate. Antiviral Res. 2020 May 4;179:104813.
3. Yang J#, Xu Y#, Yan Y, Li W, Zhao L, Dai Q, Li Y, Li S, Zhong J*, Cao R*, Zhong W*. Small Molecule Inhibitor of ATPase Activity of HSP70 as a Broad-Spectrum Inhibitor against Flavivirus Infections. ACS Infect Dis. 2020 May 8;6(5):832-843.
4. Zhang W#, Xu Y#, Zhao F, Hu G, Tarbe M, Zhou S, Wang W, Zhang S, Zhang W, Xu Q, Shi L, Yuan F, Lin X, Sun J, Zhao J, Yang Y, Liang X, Zhong J, Long G, Qin C, Leng Q*, Tang H*. Pre-existing immunity to Japanese encephalitis virus protected pathogenesis of Zika virus infection in mice. Science Bulletin. 2020 March 15;65(5):402-409.
5. Cao RY#, Xu YF#, Zhang TH, Yang JJ, Yuan Y, Hao P, Shi Y, Zhong J*, Zhong W*. Pediatric Drug Nitazoxanide: A Potential Choice for Control of Zika. Open Forum Infect Dis. 2017 Feb 3;4(1):ofx009.
